Drug Discovery


Drug Discovery Market Research Reports Analysis and Trends

Publication Single User License (PDF) Price
Synaptosomal Associated Protein 25 (SNAP-25) Inhibitors -Pipeline Insights, 2015

Synaptosomal Associated Protein 25 (SNAP-25) Inhibitors -Pipeline Insights, 2015

Date Published: May 14 2015

Summary

$1,250.00
 Labor And Delivery-Pipeline Insights, 2015

Labor And Delivery-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Labor And Delivery- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Labor And Delivery. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Labor And Delivery Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
AMP Activated Protein Kinase (AMPK) Inhibitors -Pipeline Insights, 2015

AMP Activated Protein Kinase (AMPK) Inhibitors -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, AMP Activated Protein Kinase (AMPK) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the AMP Activated Protein Kinase (AMPK) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The AMP Activated Protein Kinase (AMPK) Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Neuraminidase Inhibitors -Pipeline Insights, 2015

Neuraminidase Inhibitors -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Neuraminidase Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Neuraminidase Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Neuraminidase Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Encephalitis-Pipeline Insights, 2015

Encephalitis-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Encephalitis- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Encephalitis. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Encephalitis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Skin And Skin Structure Infections (SSSI) Caused By Bacteria-Pipeline Insights, 2015

Skin And Skin Structure Infections (SSSI) Caused By Bacteria-Pipeline Insights, 2015

Date Published: May 14 2015

Summary

$1,250.00
Glycine Reuptake Inhibitors (GlyRI) -Pipeline Insights, 2015

Glycine Reuptake Inhibitors (GlyRI) -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Glycine Reuptake Inhibitors (GlyRI)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Glycine Reuptake Inhibitors (GlyRI). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Glycine Reuptake Inhibitors (GlyRI) Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Anal Fistula -Pipeline Insights, 2015

Anal Fistula -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Anal Fistula - Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anal Fistula . The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anal Fistula Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2015

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2015

Date Published: May 14 2015

Summary

$1,250.00
Caspases Inhibitors -Pipeline Insights, 2015

Caspases Inhibitors -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Caspases Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Caspases Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Caspases Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Prostaglandin F2-Alpha Receptor Agonists -Pipeline Insights, 2015

Prostaglandin F2-Alpha Receptor Agonists -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Prostaglandin F2-Alpha Receptor Agonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Prostaglandin F2-Alpha Receptor Agonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Prostaglandin F2-Alpha Receptor Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Hepatitis A-Pipeline Insights, 2015

Hepatitis A-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Hepatitis A- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Hepatitis A. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Hepatitis A Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
5-HT1 Antagonists -Pipeline Insights, 2015

5-HT1 Antagonists -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, 5-HT1 Antagonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the 5-HT1 Antagonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The 5-HT1 Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Leukotriene D4 Antagonists -Pipeline Insights, 2015

Leukotriene D4 Antagonists -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Leukotriene D4 Antagonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Leukotriene D4 Antagonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Leukotriene D4 Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Chronic Plaque Psoriasis-Pipeline Insights, 2015

Chronic Plaque Psoriasis-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Chronic Plaque Psoriasis- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Chronic Plaque Psoriasis. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Chronic Plaque Psoriasis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Pruritus-Pipeline Insights, 2015

Pruritus-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Pruritus- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Pruritus. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Pruritus Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Ergosterol Inhibitors -Pipeline Insights, 2015

Ergosterol Inhibitors -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Ergosterol Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Ergosterol Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Ergosterol Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Transforming Growth Factor Alpha (TGFa) Inhibitors -Pipeline Insights, 2015

Transforming Growth Factor Alpha (TGFa) Inhibitors -Pipeline Insights, 2015

Date Published: May 14 2015

Summary

$1,250.00
 Mast Cell Leukemia-Pipeline Insights, 2015

Mast Cell Leukemia-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Mast Cell Leukemia- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Mast Cell Leukemia. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Mast Cell Leukemia Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Anti-CD38 Antibody -Pipeline Insights, 2015

Anti-CD38 Antibody -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Anti-CD38 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD38 Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD38 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data